Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06918067 · ClinicalTrials.gov registry record · NA
Comparison of Urinary Flow Study
A NA study of Urinary Retention, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT06918067: Recruiting NA study of Urinary Retention, sponsored by Wake Forest University Health Sciences.
NCT06918067 is a NA study of Urinary Retention that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 17 participants, below the 139-participant average among 11 other Urinary Retention trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06918067, a NA study of Urinary Retention, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to compare the urinary flow speed of two different female catheters in patients that use intermittent catheters to empty their bladder. The "14 Fr Two Eyelet Coloplast Female SpeediCath Urinary Catheter" will be compared to the "14 Fr Coloplast Micro Zone Luja Female Catheter." Participants will have one study visit that should take about an hour and will also receive a follow-up telephone call about one week after the visit.
Primary Outcome
Amount of time (seconds) it takes the urine to be released. The normal urinary flow duration for women is 15-18 ml/sec. A lower average flow rate could indicate a problem with the bladder or urinary tract.
Conditions Studied
Interventions
- DEVICE Coloplast Micro Zone Luja Female Catheter
- DEVICE Coloplast SpeediCath Female Catheter
Study Locations (1)
North Carolina
- Women's Center for Pelvic Health (Mercy) - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2025-11-06 |
| Est. Completion | 2027-03 |
| Phase | NA |
What NCT06918067 shows while recruiting
NCT06918067 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 139-participant average among 11 other Urinary Retention trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Urinary Retention appearing as the primary indexed condition, and to 2 interventions - of which Coloplast Micro Zone Luja Female Catheter is the first listed.
NCT06918067 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06918067 about?
NCT06918067 is a clinical study titled "Comparison of Urinary Flow Study". The purpose of this research study is to compare the urinary flow speed of two different female catheters in patients that use intermittent catheters to empty their bladder. The "14 Fr Two Eyelet Coloplast Female SpeediCath Urinary Catheter" will be compared to the "14 Fr Coloplast Micro Zone Luja F...
What is the current status of trial NCT06918067?
This trial is currently recruiting. It is a NA study. The enrollment target is 17 participants. The study started on 2025-11-06. Estimated completion is 2027-03.
What conditions does trial NCT06918067 study?
This clinical trial studies the following conditions: Urinary Retention.
What interventions are being tested in trial NCT06918067?
The interventions under investigation include: Coloplast Micro Zone Luja Female Catheter (DEVICE), Coloplast SpeediCath Female Catheter (DEVICE).
Who is sponsoring clinical trial NCT06918067?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06918067 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Retention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06918067's enrollment target sits among peer trials
17 11th of 11 higher than 1 of 11 other Urinary Retention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Retention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate
RECRUITING · NA
-
How the Method of Bladder Emptying After Epidural Placement in Labor Affects Postpartum Voiding
RECRUITING · NA
-
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
RECRUITING · NA
-
Effect of Chlorhexidine Gluconate Bladder Instillations in Patients With Chronic Suprapubic Catheters on Unplanned Healthcare Encounters and Quality of Life
RECRUITING · NA
-
Use of The Spanner Temporary Prostatic Stent as an Alternative to a Urinary Catheter to Achieve Bladder Drainage in Men
COMPLETED · NA
-
Superficial Peroneal Nerve Neuromodulation for Non-Obstructive Urinary Retention
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI